Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000082

Chief Scientific Officer gave up 661 shares (to pay taxes)

  • Chief Scientific Officer acquired 2,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fisher Stewart · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-30 Exercise or conversion : show line 1 in the form +2,250 104,737 D
2023-08-30 Shares withheld for taxes : show line 2 in the form −661 $2.93 $1,937 104,076 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-30 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −2,250 16,500 D
Loading xslF345X05/wk-form4_1693512618.xml…